
Study: Blood test identifies melanoma patients who will benefit most from immunotherapy
Oct. 16 (UPI) -- Cancer patients with high levels of cancer cells in their blood may benefit from receiving more aggressive drug treatment for melanoma, a study published Friday by Clinical Cancer Research found. The cancer cells, called circulating tumor DNA, could be used as a biomarker -- an indicator of bodily processes -- to help select the most effective treatment for melanoma, the researchers, from Edith Cowan University in Australia, said. Advertisement "Selecting the right course of drugs and therapies to treat melanoma is extremely complex and relies on a number of factors, including the characteristics of the tumor and how it has spread throughout the body," study co-author Elin Gray, an assistant professor at the school, said in a statement. The discovery could improve melan...